1. Home
  2. TECX vs FNLC Comparison

TECX vs FNLC Comparison

Compare TECX & FNLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • FNLC
  • Stock Information
  • Founded
  • TECX 2019
  • FNLC 1864
  • Country
  • TECX United States
  • FNLC United States
  • Employees
  • TECX N/A
  • FNLC N/A
  • Industry
  • TECX
  • FNLC Major Banks
  • Sector
  • TECX
  • FNLC Finance
  • Exchange
  • TECX Nasdaq
  • FNLC Nasdaq
  • Market Cap
  • TECX 387.1M
  • FNLC 303.4M
  • IPO Year
  • TECX 2018
  • FNLC 1999
  • Fundamental
  • Price
  • TECX $17.33
  • FNLC $25.58
  • Analyst Decision
  • TECX Buy
  • FNLC
  • Analyst Count
  • TECX 6
  • FNLC 0
  • Target Price
  • TECX $79.17
  • FNLC N/A
  • AVG Volume (30 Days)
  • TECX 488.0K
  • FNLC 23.4K
  • Earning Date
  • TECX 11-07-2025
  • FNLC 10-22-2025
  • Dividend Yield
  • TECX N/A
  • FNLC 5.76%
  • EPS Growth
  • TECX N/A
  • FNLC 18.07
  • EPS
  • TECX N/A
  • FNLC 2.81
  • Revenue
  • TECX N/A
  • FNLC $88,119,000.00
  • Revenue This Year
  • TECX N/A
  • FNLC N/A
  • Revenue Next Year
  • TECX N/A
  • FNLC N/A
  • P/E Ratio
  • TECX N/A
  • FNLC $8.99
  • Revenue Growth
  • TECX N/A
  • FNLC 12.70
  • 52 Week Low
  • TECX $13.70
  • FNLC $22.11
  • 52 Week High
  • TECX $61.07
  • FNLC $31.05
  • Technical
  • Relative Strength Index (RSI)
  • TECX 51.64
  • FNLC 50.57
  • Support Level
  • TECX $16.91
  • FNLC $25.19
  • Resistance Level
  • TECX $19.93
  • FNLC $25.85
  • Average True Range (ATR)
  • TECX 1.44
  • FNLC 0.57
  • MACD
  • TECX 0.29
  • FNLC 0.11
  • Stochastic Oscillator
  • TECX 52.98
  • FNLC 84.30

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About FNLC First Bancorp Inc (ME)

First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.

Share on Social Networks: